成都治疗脉管炎哪种方法好成都看小腿静脉曲张要多少钱,成都治疗下肢动脉硬化那便宜,成都那个医院做精索静脉曲张好,成都婴幼儿血管瘤怎样治,精索静脉曲张医院在什么地方啊成都,成都血管畸形哪家医院做的好,成都春熙路医院精索静脉曲张

GENEVA, March 28 (Xinhua) -- The world is ill-prepared to respond to a severe influenza pandemic or to any similarly global, sustained, and threatening public health emergency, an independent expert-committee entrusted by World Health Organization (WHO) said at its fourth meeting here on Monday.The Review Committee, tasked to look into the experience gained in the global response to the influenza A (H1N1) pandemic in 2009, issued its preliminary report at the meeting.In the report, the Committee said, "global preparedness can be advanced through research, strengthened health-care delivery systems, economic development in low and middle-income countries and improved health status."It recommended that international society establish an extensive global public health reserve corps consisted of experts and public health professionals, which could be deployed to support countries in need, in case of future pandemics.Another suggestion was to create a contingency fund for public health emergencies to be held in trust at an institution such as the World Bank, in order to provide financial support during a declared public health emergency of international concern.The report also urged WHO member states to reach an agreement on sharing of viruses and access to vaccines, and encouraged them to run independent or cooperative influenza research program.WHO Director-General Margaret Chan said at the opening of the meeting that the report had offered "critical guidance to all ministers of health who need to make far-reaching decisions."She said the recommendations in the report would help to " improve the capacity of WHO and the international community to respond to public health emergencies" and therefore should be taken with "added urgency."In January 2010, WHO's Executive Board established a Review Committee, at Chan's proposal, to review the experience gained in response to the H1N1 pandemic, as well as the International Health Regulations and WHO's functioning in tackling the disease.The Committee is expected to prepare its final report out of the current preliminary version, and submit it to the decision- making body of WHO in May.

LOS ANGELES, April 7 (Xinhua) -- A new research has found that about nine million people in the United States identify themselves as lesbian, gay, bisexual or transgender (LGBT).About 1.8 percent of adults identify themselves as bisexual, 1. 7 percent as gay or lesbian, and 0.03 percent as transgender, researchers at the University of California-Los Angeles' School of Law said in the study published by The Los Angeles Times on Thursday.The study culled data and methods from nine surveys conducted over the last seven years and averaged results from five of those surveys to estimate sexual orientation and from two surveys to estimate the transgender population.The findings also show that about 8.2 percent of Americans said they participated in same-sex sexual activity and about 11 percent said they had some same-sex sexual attraction, but neither of these groups necessarily identified themselves as LGBT.The researchers noted that insufficient and inconsistent national surveys make it difficult to get an estimate of the LGBT population in the United States, according to the Times report.

BEIJING, Feb. 20 (Xinhua) -- China's railways handled 7.13 million passengers Saturday, setting a new one day record, the Ministry of Railways (MOR) said Sunday.The figure was 16 percent higher year on year, the MOR said.Chinese railways are witnessing a new wave of travel after the Lantern Festival celebration (the 15th day of the first month in the Lunar New Year) Thursday, which is considered a symbolic ending of the festival season.China's Spring Festival fell on Feb. 3 this year.The busy Spring Festival transportation season runs for 40 days and is calculated in two phases: 15 days before the Spring Festival and 25 days after the Spring Festival.

WASHINGTON, March 22 (Xinhua) -- A long-term study by Greek researchers has shown the effectiveness of replacing bone marrow, purposely destroyed by chemotherapy, with autologous (self) stem cells in treating people with aggressive forms of multiple sclerosis (MS).The study was published on Tuesday in Neurology, the medical journal of the American Academy of Neurology.For the treatment, chemotherapy drugs are used to kill all of the patient's blood cells, including the immune cells that are believed to be attacking the body's own central nervous system. Bone marrow stem cells removed from the patient are purified and transplanted back into the body, which saves life by replacing the blood cells and also is proposed to "reboot" the immune system.A human embryonic stem cell line derived at Stanford University is seen in this handout photo released to Reuters by the California Institute for Regenerative Medicine, March 9, 2009The study followed 35 people for an average of 11 years after transplant. The study involved people with rapidly progressive MS who had tried a number of other treatments for MS with little or no effect. All were severely disabled by the disease, with an average score of six on a scale of disease activity that ranges from zero being a normal neurological examination to 10 meaning death due to MS.A score of six means able to walk with a cane or crutch; a seven is mainly in a wheelchair. All had worsened by at least one point on the scale in the year prior to the transplant.After the transplants, the probability of participants having no worsening of their disease for 15 years was 25 percent. The probability was higher -- 44 percent -- for those who had active brain lesions, which are a sign of disease activity, at the time of the transplant.For 16 people, symptoms improved by an average of one point on the scale after the transplant, and the improvements lasted for an average of two years. The participants also had a reduction in the number and size of lesions in their brains. Two people (six percent) died from complications related to the transplant at two months and 2-1/2 years post-transplant.Study author Vasilios Kimiskidis, of Aristotle University in Thessaloniki, Greece, noted that more research is needed on this treatment, including studies that compare people receiving the treatment to a control group that does not receive the treatment."Keeping that in mind, our feeling is that stem cell transplants may benefit people with rapidly progressive MS," he said. "This is not a therapy for the general population of people with MS but should be reserved for aggressive cases that are still in the inflammatory phase of the disease."